|Bid||149.64 x 100|
|Ask||150.87 x 200|
|Day's Range||149.57 - 150.30|
|52 Week Range||120.75 - 150.30|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.07%|
Hopes for Trump's tax reforms, abating North Korea fears, lower-than-expected damage from Hurricane Irma and record stock market highs rekindled the love for U.S. equity ETFs last week.
Small-capitalization stock investors were defensive going into the 2017, but they have quickly changed their tune, turning to more growth-weighted smaller company picks. Investors can also gain diversified ...
Acadia Pharmaceuticals (ACAD) plans to focus on long-term care (or LTC) facilities to boost Nuplazid’s adoption in the Parkinson’s disease (or PD) psychosis indication.